本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pacira Pharmaceuticals

24.08
-0.6000-2.43%
盤後24.080.00000.00%19:30 EDT
成交量:82.45萬
成交額:1,977.80萬
市值:9.60億
市盈率:68.45
高:24.94
開:24.63
低:23.65
收:24.68
52周最高:27.66
52周最低:18.80
股本:3,986.19萬
流通股本:3,636.93萬
量比:1.56
換手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
淨資產收益率:2.05%
總資產收益率:1.48%
市淨率:1.43
市盈率(LYR):152.57

資料載入中...

2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

重要事件披露

Form 8-K - Current report
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]